Efalizumab for Patients With Moderate to Severe Plaque Psoriasis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efalizumab for Patients With Moderate to Severe Plaque Psoriasis

Published:2003-12-17 Issue:23 Volume:290 Page:3073
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Gordon Kenneth B.,Papp Kim A.,Hamilton Tiffani K.,Walicke Patricia A.,Dummer Wolfgang,Li Nicole,Bresnahan Brian W.,Menter Alan,for the Efalizumab Study Group

Publisher

American Medical Association (AMA)

Subject

General Medicine

Cited by 352 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted therapy for immune mediated skin diseases. What should a dermatologist know?;Anais Brasileiros de Dermatologia;2024-07

2. A systematic review investigating at what proportion clinical images are shared in prospective randomized controlled trials involving patients with psoriasis and biological agents;Journal of Dermatological Treatment;2023-11-15

3. A Critical Analysis of the FDA’s Omics-Driven Pharmacodynamic Biomarkers to Establish Biosimilarity;Pharmaceuticals;2023-11-02

4. A systematic review of 454 randomized controlled trials using the Dermatology Life Quality Index: experience in 69 diseases and 43 countries;British Journal of Dermatology;2023-03-27

5. Targeting integrin pathways: mechanisms and advances in therapy;Signal Transduction and Targeted Therapy;2023-01-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP